Page last updated: 2024-08-25

3-deazaneplanocin and Squamous Cell Carcinoma of Head and Neck

3-deazaneplanocin has been researched along with Squamous Cell Carcinoma of Head and Neck in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Endo-Munoz, L; Gannon, OM; Hazar-Rethinam, M; Merida de Long, L; Saunders, NA1

Other Studies

1 other study(ies) available for 3-deazaneplanocin and Squamous Cell Carcinoma of Head and Neck

ArticleYear
Dysregulation of the repressive H3K27 trimethylation mark in head and neck squamous cell carcinoma contributes to dysregulated squamous differentiation.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2013, Jan-15, Volume: 19, Issue:2

    Topics: Adenosine; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Head and Neck Neoplasms; Histones; Humans; Methylation; Mice; Polycomb Repressive Complex 2; RNA Interference; Squamous Cell Carcinoma of Head and Neck; Transplantation, Heterologous

2013